Purpose Use of stereotactic body radiation therapy (SBRT) is increasing in patients with
localized prostate cancer, but concerns about early and late gastrointestinal (GI) and …

Background Stereotactic body radiotherapy (SBRT) is gaining wider adoption for prostate
cancer management but there remain significant toxicity risks when delivering prostate …

Background Stereotactic body radiotherapy (SBRT) is becoming increasingly used in
treating localized prostate cancer (PCa), with evidence showing similar toxicity and efficacy …

Background The recent introduction of magnetic resonance-guided radiation therapy
(MRgRT) has allowed improved treatment planning and delivery of stereotactic body …

Importance Magnetic resonance imaging (MRI) guidance offers multiple theoretical
advantages in the context of stereotactic body radiotherapy (SBRT) for prostate cancer …

Background and purpose Magnetic resonance-guided radiation therapy (MRgRT) has
recently become available in clinical practice and is expected to expand significantly in …

Background There is growing evidence that prostate cancer (PC) cells are more sensitive to
high fraction dose in hypofractionation schemes. High-dose-rate (HDR) brachytherapy as …

Purpose The radiobiology of prostate cancer may favor the extreme hypofractionation
inherent in stereotactic body radiation therapy (SBRT); however, data from a large …

PURPOSE: To evaluate the validity of the chosen adaptive radiotherapy (ART) dose–volume
constraints while testing the hypothesis that toxicity would not be greater at higher tumor …

Abstract Background Unity Elekta is a unique magnetic resonance (MR)-linac that
conjugates a 1.5 Tesla MR unit with a 7 MV flattening filter free accelerator. A prospective …